| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Pinto Shelly | SVP, FINANCE AND CAO | C/O ALX ONCOLOGY HOLDINGS INC., 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO | /s/ Shelly Pinto | 07 Jan 2026 | 0001857740 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALXO | Common Stock | Sale | $4,357 | -3,925 | -4.3% | $1.11 | 88,273 | 06 Jan 2026 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units. |
| F2 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.11 to $1.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| F3 | Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on December 31, 2025. |